Cargando…
Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern
The ability of SARS-CoV-2 to evolve in response to selective pressures poses a challenge to vaccine and antiviral efficacy. The S1 subunit of the spike (S) protein contains the receptor-binding domain and is therefore under selective pressure to evade neutralizing antibodies elicited by vaccination...
Autores principales: | Schmitz, Katharina S., Geers, Daryl, de Vries, Rory D., Bovier, T. Francesca, Mykytyn, Anna Z., Geurts van Kessel, Corine H., Haagmans, Bart L., Porotto, Matteo, de Swart, Rik L., Moscona, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239157/ https://www.ncbi.nlm.nih.gov/pubmed/35695453 http://dx.doi.org/10.1128/mbio.01249-22 |
Ejemplares similares
-
Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2020) -
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2021) -
Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates
por: Mathieu, Cyrille, et al.
Publicado: (2018) -
Antiviral Lipopeptide-Cell Membrane Interaction Is Influenced by PEG Linker Length
por: Augusto, Marcelo T., et al.
Publicado: (2017) -
Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets
por: Rijsbergen, Laurine C., et al.
Publicado: (2022)